Last Price
2.38
Today's Change
-0.08 (3.25%)
Day's Change
2.23 - 2.53
Trading Volume
113,247
Market Cap
82 Million
Shares Outstanding
34 Million
Avg Volume
403,004
Avg Price (50 Days)
2.87
Avg Price (200 Days)
6.26
PE Ratio
-4.58
EPS
-0.52
Earnings Announcement
26-Feb-2025
Previous Close
2.46
Open
2.46
Day's Range
2.23 - 2.5341
Year Range
1.078 - 46.0
Trading Volume
113,247
1 Day Change
-3.25%
5 Day Change
-5.18%
1 Month Change
-26.77%
3 Month Change
27.96%
6 Month Change
-64.48%
Ytd Change
-91.82%
1 Year Change
-91.82%
3 Year Change
-91.82%
5 Year Change
-91.82%
10 Year Change
-91.82%
Max Change
-91.82%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.